allergies

← RETURN TO PRE-TRANSPLANT GUIDE
Education • Allergies • Immunosuppression

Seasonal Allergies and Immunosuppression: An In-depth Overview

Seasonal allergic rhinitis is an IgE-mediated inflammatory response to airborne allergens (trees, grasses, weeds). Immunosuppression—especially after organ transplant—changes infection risk and medication safety considerations, but does not reliably eliminate allergy symptoms. [1] [2] [3]

Sneezing (illustrative seasonal allergy symptom)
Sneezing and nasal symptoms can overlap with infections. In immunosuppressed patients, persistent or atypical symptoms should prompt a careful infection evaluation. [4]
Education – Seasonal Allergies & Immunosuppression How Seasonal Allergies Work What Immunosuppression Changes Treatment Options Drug Interactions & Safety Immunotherapy Alternative Therapies When to Call Your Team References
Education – Seasonal Allergies & Immunosuppression Treatment Interactions Red Flags References

Introduction

Seasonal allergies (seasonal allergic rhinitis) occur when the immune system reacts to airborne allergens—most commonly pollens—triggering mediator release and mucosal inflammation. Evidence-based guidance supports allergen avoidance strategies, intranasal corticosteroids, and antihistamines as common first-line therapies. [1]

Immunosuppression is a reduction in immune activity—often medically induced after organ transplantation to prevent rejection. While immunosuppression modulates immune pathways, it does not reliably prevent IgE-mediated allergy, and it increases infection risk and medication interaction risk. [2] [3]

Clinical mindset: Treat allergies appropriately—but keep a low threshold to evaluate for infection if symptoms are atypical, prolonged, or systemic.

How Seasonal Allergies Work

In sensitized people, inhaled allergens bind IgE on mast cells and basophils, triggering mediator release (histamine, leukotrienes) and downstream inflammation in the nasal mucosa and conjunctiva. Symptoms often follow a seasonal pattern and include itching, sneezing, watery eyes, rhinorrhea, and congestion. [1]

Pattern recognition: Itching + clear drainage + predictable seasonality points to allergy. Fever, worsening facial pain, purulent drainage, or shortness of breath suggests infection—especially in immunosuppressed patients.

What Immunosuppression Changes (and What It Doesn’t)

Immunosuppressive medications reduce immune responsiveness to prevent allograft rejection, but they also increase susceptibility to certain infections and malignancies. Allergic disease can still occur under immunosuppression; it is not safe to assume that transplant medications will “cover” seasonal allergies. [2] [3]

Key risk tradeoff: Some therapies can reduce inflammation, but infection risk remains elevated. New or escalating symptoms should be interpreted with that risk in mind.

Treatment Options

Step 1: Environmental control

  • Monitor pollen counts; keep windows closed during high counts; consider HEPA filtration.
  • Shower/change clothes after outdoor exposure; rinse hair at night.
  • Saline nasal irrigation can reduce allergen load (use sterile/distilled water; clean devices).

Step 2: Intranasal corticosteroids

Intranasal corticosteroids are strongly supported in practice parameters as highly effective therapy for persistent allergic rhinitis. [1]

Step 3: Antihistamines (oral or intranasal)

Second-generation oral antihistamines are often preferred for less sedation; intranasal antihistamines are also guideline-supported and can be useful for rapid symptom control. [1]

Common escalation approach: daily intranasal corticosteroid + add intranasal antihistamine or an oral second-generation antihistamine if symptoms persist. [1]

Drug Interactions & Safety (Transplant-Relevant)

Transplant immunosuppressants can have narrow therapeutic ranges and clinically meaningful interactions. Because many interactions occur through CYP3A pathways and other mechanisms, new OTC medications and supplements should be cleared with your transplant team or pharmacist before use. [6] [7]

Grapefruit warning: FDA communications and tacrolimus labeling warn that grapefruit can increase drug exposure, potentially raising toxicity risk. [6] [7]

Practical OTC cautions

  • Decongestants can raise blood pressure/heart rate—relevant in renal/cardiovascular disease.
  • Combo cold/flu products increase dosing errors; avoid unless your team approves.
  • Supplements may be contaminated, hepatotoxic, or interactive—clear them first.

Immunotherapy

Allergen immunotherapy (shots or sublingual forms) can be effective for selected patients with documented IgE-mediated disease when standard therapy is insufficient or not tolerated. [1]

Immunosuppressed patients: immunotherapy may require individualized risk/benefit assessment and coordination between allergist and transplant team. [9]

Alternative Therapies

Butterbur

LiverTox describes reports of liver injury associated with some commercial butterbur products, with concerns about residual pyrrolizidine alkaloids or contamination. In liver disease and post-transplant patients, the safety threshold should be high. [10]

Quercetin

Human evidence is mixed; some clinical studies have explored symptom outcomes, but conclusions remain limited and product quality varies. [11]

Acupuncture

Randomized trial data suggest improvements in allergic rhinitis quality-of-life outcomes and antihistamine use in some populations, though effect size and reproducibility vary. [12]

Transplant rule: If it is swallowed, injected, or applied regularly—treat it like a medication. Clear it with your transplant team.

When to Call Your Transplant Team

  • Fever, chills, night sweats, or “flu-like” systemic symptoms
  • New/worsening shortness of breath, wheezing, chest pain
  • Severe facial pain/pressure, thick purulent nasal drainage
  • Persistent cough or new sputum production
  • Inability to keep down medications or missed immunosuppression doses
  • Plan to start a new OTC product or supplement you have not previously used
Do not self-adjust immunosuppression. Allergy treatment should be added safely—not by changing transplant medications without guidance.

References

  1. AAAAI/ACAAI. Rhinitis 2020: A Practice Parameter Update (Dykewicz et al.).
  2. Halloran PF. Immunosuppressive Drugs for Kidney Transplantation. New England Journal of Medicine (2004) (general transplant immunosuppression principles).
  3. Dehlink E, et al. Immunosuppressive therapy does not prevent IgE-mediated allergies in pediatric organ transplant recipients. Pediatrics (2006).
  4. LiverTransplantGuide.com. “Sneeze” media file (page hero media).
  5. U.S. FDA. Grapefruit Juice and Some Drugs Don’t Mix.
  6. U.S. FDA. Prograf (tacrolimus) Prescribing Information (interaction warnings).
  7. StatPearls (NCBI Bookshelf). Allergy Immunotherapy: indications and patient selection.
  8. LiverTox (NIH/NCBI). Butterbur (reports of liver injury; safety considerations).
  9. Yamada S, et al. Quercetin-containing supplement intake and pollinosis symptoms (clinical study). (2022).
  10. Brinkhaus B, et al. Acupuncture in patients with seasonal allergic rhinitis: randomized trial. Ann Intern Med (2013).
Educational content — not a substitute for medical advice. Always consult your hepatologist, transplant team, allergist, or pharmacist for personal recommendations and medication-interaction checks.
© Dr. Michael Baruch · LiverTransplantGuide.com
← RETURN TO PRE-TRANSPLANT GUIDE
```